Stock analysts at Leerink Partnrs boosted their FY2025 earnings estimates for shares of Disc Medicine in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates ...

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has been assigned an average rating of “Buy” from the ten ratings firms ...